Alvogen, Inc. Company Profile

07:55 EDT 30th August 2015 | BioPortfolio

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic selection of products, partners and markets, and the utilization of a consolidated global supply chain. The company has more than 130 pharmaceutical products in development and registration with several products expected to be launched in 2010. The product portfolio consists of a broad range of leading molecules for the treatment of conditions in the areas of Oncology, Cardiology, Respiratory, Neurology and Gastroenterology.


News Articles [19 Associated News Articles listed on BioPortfolio]

Alvogen buys four-drug portfolio from Pfizer

Alvogen has entered into a agreement with Pfizer to purchase a portfolio of four pharmaceutical products for the US market, which Pfizer is obliged to divest as a condition of its imminent acquisition...

Alvogen To Merge Korean Units, Plans Asian Expansion

U.S.-based pharmaceutical company Alvogen will merge its two South Korean subsidiaries - Kunwha Pharm and Dream Pharma - to create a new unit, Alvogen Korea, in June as part of its goal to become one ...

Alvogen to buy product portfolio from Pfizer

Generic drug company Alvogen said it has agreed to buy a portfolio of four pharmaceutical products, in…

CVC Capital Partners leads consortium to acquire controlling stake in Alvogen

Consortium will provide funds to help Alvogen become a leading generics player worldwide

Alvogen To Buy Product Portfolio From Pfizer For U.S. Market

NEW YORK CITY (dpa-AFX) - Privately-held pharmaceutical company Alvogen said Wednesday that it has agreed to acquire from Pfizer Inc. (PFE) a portfolio of four pharmaceutical products in the U.S.,...

Alvogen to buy Pfizer Drugs for US Market

US pharma company Alvogen has agreed to buy four of Pfizer’s products in the USA. The sale is part of Pfizer’s condition in closing its $17 billion acquisition of Hospira.

Alvogen First to Bulgarian Market with Generic Version of VelcadeTM

PINEBROOK, N.J.–(BUSINESS WIRE)–Alvogen today announced it has launched the first generic version of the cancer drug VelcadeTM (Bortezomib) in Bulgaria. The drug will be marketed under the...

Alvogen To Acquire Four Pharma Products From Pfizer

NEW YORK CITY (dpa-AFX) - Alvogen announced it has entered into a definitive agreement with Pfizer Inc. (PFE), under which the company will acquire a portfolio of four pharmaceutical products, in ...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [4 Associated Companies listed on BioPortfolio]

Alvogen Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen Pharma US, Inc.

Alvogen is a multinational, privately-owned pharmaceuticals company, focused on developing, manufacturing and distributing generic, brand, over-the-counter brands (OTC) and biosim...

Alvogen, Inc. Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

Alvogen, Inc.

Alvogen is a multinational pharmaceuticals company focused on complex generic products. Alvogen is committed to build the next-generation generics company through the strategic se...

More Information about "Alvogen, Inc." on BioPortfolio

We have published hundreds of Alvogen, Inc. news stories on BioPortfolio along with dozens of Alvogen, Inc. Clinical Trials and PubMed Articles about Alvogen, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alvogen, Inc. Companies in our database. You can also find out about relevant Alvogen, Inc. Drugs and Medications on this site too.


Advertisement
 

Relevant Topics

Generics Drugs
Latest News Clinical Trials Research Drugs Reports Corporate
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Cancer
Latest News Clinical Trials Research Drugs Reports Corporate
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cardiology
Latest News Clinical Trials Research Drugs Reports Corporate
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...

Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record